Stay updated on Xospata Safety in Relapsed AML Clinical Trial
Sign up to get notified when there's something new on the Xospata Safety in Relapsed AML Clinical Trial page.

Latest updates to the Xospata Safety in Relapsed AML Clinical Trial page
- Check7 days agoChange DetectedA site-wide notice about potential delays due to a lapse in government funding was added, and the release version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check14 days agoChange DetectedUI/visual updates to the history view add a glossary toggle, green/red highlights for additions and deletions, and minor wording tweaks including revision info (v3.4.0).SummaryDifference0.6%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4 in the footer, indicating a system update rather than new or altered study data, and there are no changes to study details or records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded Revision: v3.3.3 to the page history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer/metadata.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision v3.3.2 was added to the history and the previous revision v3.3.1 was removed from the list.SummaryDifference0.1%

- Check79 days agoChange DetectedSite-wide version update from v3.2.0 to v3.3.1; no changes to the study record content or history entries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Xospata Safety in Relapsed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Xospata Safety in Relapsed AML Clinical Trial page.